查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1933100

全球女性用荷爾蒙平衡和經期健康產品市場預測（至2032年）：按產品、配方、成分類型、分銷管道、應用、最終用戶和地區分類

Women's Hormonal Balance & Menstrual Wellness Products Market Forecasts to 2032 - Global Analysis By Product, Formulation, Ingredient Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，預計到 2025 年，全球女性用荷爾蒙平衡和月經健康產品市場價值將達到 50.1 億美元，到 2032 年將達到 84.3 億美元，預測期內複合年成長率為 7.7%。

女性用荷爾蒙平衡和經期健康產品是指旨在支持荷爾蒙調節、緩解經期不適並維護女性在各個生命階段整體生殖健康的消費者健康和保健解決方案。這些產品針對月經症候群 (PMS)、經痛、月經、更年期症狀、情緒波動和精力不足等問題。此類別包括膳食補充劑、機能性食品、飲料、草藥配方和外用補充劑，它們利用維生素、礦物質、植物萃取物和益生菌，安全地促進荷爾蒙平衡、緩解不適並提高生活品質。這些產品迎合了現代生活方式和全球對預防性醫療保健的需求。

荷爾蒙失調症呈上升趨勢

現代生活方式、壓力、不良飲食習慣以及環境中的內分泌干擾物，導致育齡女性以及更年期和閉經後女性的荷爾蒙健康問題日益增多。人們對荷爾蒙相關疾病的認知不斷提高，促使女性尋求預防性和長期的健康解決方案。醫療保健專業人員也擴大推薦營養保健品、機能性食品和草藥配方作為傳統治療方法的補充。診斷工具的進步和數位健康平台的普及使得荷爾蒙異常的早期檢測成為可能。社群媒體上關於月經健康和荷爾蒙健康的討論活性化，正在減少社會偏見，並促進相關產品的使用。隨著女性越來越重視整體性和自我管理的健康，市場需求持續穩定成長。

科學檢驗有限

許多產品依賴傳統或草藥成分，但缺乏大規模、同行評審的科學研究來支持​​其功效。監管機構通常要求提供可靠的證據來支持健康聲明，這給製造商帶來了合規方面的挑戰。調查方法的不一致和成分品質的差異進一步加劇了功效檢驗。缺乏標準化的臨床數據會削弱醫療專業人員和謹慎消費者的信任。由於成本高昂且監管複雜，小規模品牌往往難以資金籌措長期臨床試驗的資金。因此，缺乏科學支持會延緩產品獲得市場認可和廣泛的機構接受。

擴展到停經前期和更年期

處於更年期這一人生階段的女性越來越傾向於尋求非荷爾蒙、天然的解決方案來應對潮熱、情緒波動、疲勞和睡眠障礙等症狀。預期壽命的延長和女性人口老化正在擴大全球目標消費群體。各大品牌正不斷創新，研發出能夠支持荷爾蒙平衡、骨骼健康和情緒健康的專業配方。人們對更年期相關挑戰的討論日益增多，這推動了相關知識的普及和產品的使用。醫療保健專業人員也擴大建議在藥物治療之外，結合生活方式和營養療法。這種轉變使企業能夠豐富其產品系列，並加強與客戶參與。

仿冒品的興起

不受監管的線上市場和非正規通路使得仿冒品很容易進入供應鏈。這些產品往往缺乏品管、準確的標籤和安全的成分濃度。仿冒品會削弱消費者的信任，並威脅合法製造商的品牌聲譽。與欺詐性和標籤錯誤的保健品相關的健康風險也可能導致整個行業受到更嚴格的監管審查。為了解決這個問題，企業必須在防偽技術和供應鏈透明度方面投入大量資金。

新冠疫情的影響：

新冠疫情對女性用荷爾蒙平衡和經期健康產品市場產生了複雜的影響。疫情初期的封鎖措施擾亂了生產、原料採購和實體零售通路。然而，人們對免疫力、心理健康和整體健康的日益關注，帶動了對荷爾蒙平衡和經期健康產品的需求成長。疫情期間壓力造成的荷爾蒙失衡進一步刺激了消費者的需求。隨著消費者轉向線上購物，電商平台經歷了快速成長。品牌加速推動數位化行銷和遠端醫療整合，以維持客戶參與。疫情後，韌性、全通路策略和在地化生產已成為關鍵優先事項。

預計在預測期內，片劑和膠囊劑型將佔據最大的市場佔有率。

由於片劑和膠囊劑型相比液體劑型具有服用方便、劑量控制精準、保存期限長等優點，預計在預測期內將佔據最大的市場佔有率。藥片和膠囊劑型是維生素、礦物質、益生菌和草藥萃取物的常用給藥方式。製造商青睞這種劑型，是因為它擴充性生產且成本效益高。消費者也認為膠囊劑型便於攜帶，是日常服用補充劑的理想選擇。膠囊封裝技術的進步提高了產品的生物利用度和吸收率。

在預測期內，線上零售板塊將呈現最高的複合年成長率。

預計在預測期內，線上零售領域將保持最高的成長率，因為網路普及率和智慧型手機使用量的不斷提高正在改變女性獲取健康產品的方式。線上平台提供隱私保護、豐富的產品選擇和深入的教育內容，這在購買月經和荷爾蒙健康產品時尤其重要。訂閱模式和個人化產品推薦正在提高客戶維繫。網紅行銷和數位行銷宣傳活動正在加速線上使用量的成長。跨境電商也幫助品牌觸達尚未開發的市場。

佔比最大的地區：

由於消費者健康意識高，且積極主動地進行健康管理，預計北美將在預測期內佔據最大的市場佔有率。越來越多的女性尋求具有科學依據的膳食補充劑和功能性健康產品。成熟品牌的強大影響力以及持續的產品創新正在推動市場擴張。完善的法規結構有助於建立消費者對產品安全性和品質的信任。此外，數位健康科技和訂閱式健康服務的廣泛應用也使該地區受益匪淺。

年複合成長率最高的地區：

在預測期內，亞太地區預計將實現最高的複合年成長率，這主要得益於女性健康意識的提高和可支配收入的增加。在印度、中國和日本等國家，膳食補充劑和草藥保健方案的接受度不斷提高。人們對傳統醫療體系的文化親和性也促進了產品的普及。政府為促進女性健康和營養而採取的措施將進一步推動市場成長。零售網路和電子商務平台的擴張也提高了產品的可及性。

免費客製化服務：

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 基於產品系列、地域覆蓋範圍和策略聯盟對主要參與者進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球女性用荷爾蒙平衡與經期健康產品市場（依產品分類）

  • 荷爾蒙平衡補充劑
    • 植物雌激素補充劑
    • 黃體素補充劑
    • DHEA/腎上腺支持
    • 草本/植物混合物
    • Omega-3營養複合物
  • 經期健康產品
    • 緩解經前症候群/月經疼痛
    • 情緒和能量支持補充劑
    • 激素追蹤設備和應用程式
    • 月經衛生用品
    • 穿戴式診斷墊
  • 機能性食品和飲料
  • 荷爾蒙療法和醫療設備

6. 全球女性用荷爾蒙平衡與經期健康產品市場（依配方分類）

  • 片劑和膠囊
  • 軟糖/咀嚼片
  • 粉末和飲料沖劑
  • 液體和糖漿
  • 貼片和創新配方

7. 全球女性用荷爾蒙平衡與經期健康產品市場（按成分類型分類）

  • 維生素和礦物質
  • 草本萃取物/適應原
  • 益生菌
  • Omega-3脂肪酸
  • 特殊化合物

8. 全球女性用荷爾蒙平衡和經期健康產品市場（按分銷管道分類）

  • 線上零售
  • 藥房和藥品商店
  • 超級市場和大賣場
  • 專業保健食品店
  • 訂閱服務

9. 全球女性用荷爾蒙平衡與經期健康產品市場（按應用領域分類）

  • 經前症候群症狀支持
  • 荷爾蒙平衡調整
  • 生育和週期管理支持
  • 更年期和圍閉經支持
  • 情緒和精力提升
  • 緩解疼痛和腫脹

10. 全球女性用荷爾蒙平衡和經期健康產品市場（按最終用戶分類）

  • 青春期/青少年
  • 育齡婦女
  • 閉經婦女
  • 閉經和停經後婦女
  • 醫療保健提供者和醫療機構
  • 其他

11. 全球女性用荷爾蒙平衡與經期健康產品市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Amway
  • Swisse Wellness
  • GNC Holdings
  • Vitabiotics
  • Herbalife International of America
  • NOW Foods
  • Nature's Bounty
  • Pure Encapsulations
  • Pharmavite LLC
  • Garden of Life
  • USANA Health Sciences
  • Archer Daniels Midland Company
  • GlaxoSmithKline
  • RBK Nutraceuticals
  • MetP Pharma AG
Product Code: SMRC33668

According to Stratistics MRC, the Global Women's Hormonal Balance & Menstrual Wellness Products Market is accounted for $5.01 billion in 2025 and is expected to reach $8.43 billion by 2032 growing at a CAGR of 7.7% during the forecast period. Women's Hormonal Balance and Menstrual Wellness Products refer to consumer health and wellness solutions designed to support hormonal regulation, menstrual comfort, and overall reproductive well-being across different life stages. These products address concerns such as PMS, cramps, cycle irregularity, menopause symptoms, mood changes, and energy levels. The category includes supplements, functional foods, beverages, herbal formulations, and topical aids that use vitamins, minerals, botanicals, and probiotics to promote balance, alleviate discomfort, and enhance daily quality of life safely for modern lifestyles and preventive care needs globally.

Market Dynamics:

Driver:

Growing prevalence of hormonal disorders

Modern lifestyles, stress, poor dietary habits, and environmental endocrine disruptors are contributing to rising hormonal health issues across reproductive-age and perimenopausal women. Greater awareness of hormone-related symptoms has encouraged women to seek preventive and long-term wellness solutions. Healthcare professionals are increasingly recommending nutraceuticals, functional foods, and herbal formulations as complementary approaches to conventional treatments. Improved diagnostic tools and digital health platforms are also enabling earlier identification of hormonal irregularities. Growing discussions around menstrual health and hormonal wellness on social media are reducing stigma and boosting product adoption. As women prioritize holistic and self-managed healthcare, market demand continues to expand steadily.

Restraint:

Limited scientific validation

Several products rely on traditional or herbal ingredients that have limited large-scale, peer-reviewed scientific studies supporting their efficacy. Regulatory authorities often demand robust evidence to substantiate health claims, creating compliance challenges for manufacturers. Inconsistent research methodologies and varying ingredient quality further complicate validation efforts. This lack of standardized clinical data can reduce trust among healthcare practitioners and cautious consumers. Smaller brands often struggle to fund long-term clinical trials due to high costs and regulatory complexity. As a result, limited scientific backing may slow market credibility and wider institutional acceptance.

Opportunity:

Expansion into perimenopause & menopause

Women in this life stage increasingly seek non-hormonal and natural solutions to manage symptoms such as hot flashes, mood swings, fatigue, and sleep disturbances. Rising life expectancy and an aging female population are enlarging the target consumer base globally. Brands are innovating with targeted formulations that support hormonal transitions, bone health, and emotional well-being. Increased openness in discussing menopause-related challenges is improving awareness and product uptake. Healthcare providers are also more willing to recommend lifestyle-based and nutritional interventions alongside medical treatments. This shift is enabling companies to diversify portfolios and strengthen long-term customer engagement.

Threat:

Rise of counterfeit products

Unregulated online marketplaces and informal distribution channels make it easier for fake products to enter the supply chain. These products often lack quality control, accurate labeling, or safe ingredient concentrations. Counterfeits can undermine consumer trust and damage brand reputation across legitimate manufacturers. Health risks associated with adulterated or mislabeled supplements may also invite stricter regulatory scrutiny for the entire sector. Companies must invest heavily in authentication technologies and supply chain transparency to combat this issue.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the women's hormonal balance and menstrual wellness products market. Initial lockdowns disrupted manufacturing, raw material sourcing, and physical retail distribution channels. However, heightened focus on immunity, mental health, and overall wellness led to increased interest in hormonal and menstrual health products. Stress-induced hormonal irregularities during the pandemic further boosted consumer demand. E-commerce platforms experienced rapid growth as consumers shifted to online purchasing. Brands accelerated digital marketing and telehealth collaborations to maintain customer engagement. Post-pandemic, resilience, omnichannel strategies, and localized production have become key priorities.

The tablets & capsules segment is expected to be the largest during the forecast period

The tablets & capsules segment is expected to account for the largest market share during the forecast period, driven by ease of consumption, precise dosage control, and longer shelf life compared to liquid formats. Tablets and capsules are widely preferred for delivering vitamins, minerals, probiotics, and herbal extracts. Manufacturers favor this format due to scalable production and cost efficiency. Consumers also associate capsules with convenience and portability for daily supplementation. Advances in encapsulation technology are improving bioavailability and absorption rates.

The online retail segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online retail segment is predicted to witness the highest growth rate, due to increased internet penetration and smartphone usage are transforming how women access wellness products. Online platforms offer privacy, product variety, and detailed educational content, which is particularly important for menstrual and hormonal health purchases. Subscription-based models and personalized product recommendations are enhancing customer retention. Influencer marketing and digital awareness campaigns are accelerating online adoption. Cross-border e-commerce is also enabling brands to reach underserved markets.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness and proactive health management behaviors. Women increasingly seek science-backed supplements and functional wellness products. Strong presence of established brands and continuous product innovation support market expansion. Advanced regulatory frameworks help build consumer confidence in product safety and quality. The region also benefits from widespread digital health adoption and subscription-based wellness services.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising awareness of women's health issues and increasing disposable income. Countries such as India, China, and Japan are witnessing growing acceptance of nutraceuticals and herbal wellness solutions. Cultural familiarity with traditional medicine systems supports product adoption. Government initiatives promoting women's health and nutrition further strengthen market growth. Expanding retail networks and e-commerce platforms improve product accessibility.

Key players in the market

Some of the key players in Women's Hormonal Balance & Menstrual Wellness Products Market include Amway, Swisse Wellness, GNC Holdings, Vitabiotics, Herbalife International of America, NOW Foods, Nature's Bounty, Pure Encapsulations, Pharmavite LLC, Garden of Life, USANA Health Sciences, Archer Daniels Midland Company, GlaxoSmithKline, RBK Nutraceuticals, MetP Pharma AG.

Key Developments:

In January 2026, GSK plc announced that it has entered a definitive agreement to acquire RAPT Therapeutics, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases. The acquisition includes ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody, currently in phase IIb clinical development for prophylactic protection against food allergens.

In March 2025, ADM and Mitsubishi Corporation announced that both companies have signed a non-binding memorandum of understanding to form a strategic alliance to explore potential areas of future collaboration across the agriculture value chain. Together, ADM and MC are committed to creating value and driving solutions that will help shape the future of the global agriculture value chain.

Products Covered:

  • Hormonal Balance Supplements
  • Menstrual Wellness Products
  • Functional Foods & Beverages
  • Hormonal Therapies & Medical Devices

Formulations Covered:

  • Tablets & Capsules
  • Gummies & Chewables
  • Powders & Drink Mixes
  • Liquids & Syrups
  • Patches & Innovative Formats

Ingredient Types Covered:

  • Vitamins & Minerals
  • Herbal Extracts & Adaptogens
  • Probiotics
  • Omega-3 Fatty Acids
  • Specialty Compounds

Distribution Channels Covered:

  • Online Retail
  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Specialty Health Stores
  • Subscription Services

Applications Covered:

  • PMS Symptom Support
  • Hormonal Balance Regulation
  • Fertility & Cycle Tracking Support
  • Menopause & Perimenopause Support
  • Mood & Energy Enhancement
  • Pain & Bloating Relief

End Users Covered:

  • Adolescents & Teens
  • Women of Reproductive Age
  • Perimenopausal Women
  • Menopausal & Postmenopausal Women
  • Healthcare Providers & Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Product

  • 5.1 Introduction
  • 5.2 Hormonal Balance Supplements
    • 5.2.1 Phytoestrogen Supplements
    • 5.2.2 Progesterone Supplements
    • 5.2.3 DHEA & Adrenal Support
    • 5.2.4 Herbal/Botanical Blends
    • 5.2.5 Omega-3 & Nutrient Complexes
  • 5.3 Menstrual Wellness Products
    • 5.3.1 PMS & Menstrual Pain Relief
    • 5.3.2 Mood & Energy Support Supplements
    • 5.3.3 Hormone Tracking Devices & Apps
    • 5.3.4 Menstrual Hygiene Products
    • 5.3.5 Wearables & Diagnostic Pads
  • 5.4 Functional Foods & Beverages
  • 5.5 Hormonal Therapies & Medical Devices

6 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Formulation

  • 6.1 Introduction
  • 6.2 Tablets & Capsules
  • 6.3 Gummies & Chewables
  • 6.4 Powders & Drink Mixes
  • 6.5 Liquids & Syrups
  • 6.6 Patches & Innovative Formats

7 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Ingredient Type

  • 7.1 Introduction
  • 7.2 Vitamins & Minerals
  • 7.3 Herbal Extracts & Adaptogens
  • 7.4 Probiotics
  • 7.5 Omega-3 Fatty Acids
  • 7.6 Specialty Compounds

8 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Retail
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Supermarkets & Hypermarkets
  • 8.5 Specialty Health Stores
  • 8.6 Subscription Services

9 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Application

  • 9.1 Introduction
  • 9.2 PMS Symptom Support
  • 9.3 Hormonal Balance Regulation
  • 9.4 Fertility & Cycle Tracking Support
  • 9.5 Menopause & Perimenopause Support
  • 9.6 Mood & Energy Enhancement
  • 9.7 Pain & Bloating Relief

10 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By End User

  • 10.1 Introduction
  • 10.2 Adolescents & Teens
  • 10.3 Women of Reproductive Age
  • 10.4 Perimenopausal Women
  • 10.5 Menopausal & Postmenopausal Women
  • 10.6 Healthcare Providers & Clinics
  • 10.7 Other End Users

11 Global Women's Hormonal Balance & Menstrual Wellness Products Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Amway
  • 13.2 Swisse Wellness
  • 13.3 GNC Holdings
  • 13.4 Vitabiotics
  • 13.5 Herbalife International of America
  • 13.6 NOW Foods
  • 13.7 Nature's Bounty
  • 13.8 Pure Encapsulations
  • 13.9 Pharmavite LLC
  • 13.10 Garden of Life
  • 13.11 USANA Health Sciences
  • 13.12 Archer Daniels Midland Company
  • 13.13 GlaxoSmithKline
  • 13.14 RBK Nutraceuticals
  • 13.15 MetP Pharma AG

List of Tables

  • Table 1 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Balance Supplements (2024-2032) ($MN)
  • Table 4 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Phytoestrogen Supplements (2024-2032) ($MN)
  • Table 5 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Progesterone Supplements (2024-2032) ($MN)
  • Table 6 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By DHEA & Adrenal Support (2024-2032) ($MN)
  • Table 7 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Herbal/Botanical Blends (2024-2032) ($MN)
  • Table 8 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Omega-3 & Nutrient Complexes (2024-2032) ($MN)
  • Table 9 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menstrual Wellness Products (2024-2032) ($MN)
  • Table 10 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By PMS & Menstrual Pain Relief (2024-2032) ($MN)
  • Table 11 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Mood & Energy Support Supplements (2024-2032) ($MN)
  • Table 12 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormone Tracking Devices & Apps (2024-2032) ($MN)
  • Table 13 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menstrual Hygiene Products (2024-2032) ($MN)
  • Table 14 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Wearables & Diagnostic Pads (2024-2032) ($MN)
  • Table 15 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Functional Foods & Beverages (2024-2032) ($MN)
  • Table 16 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Therapies & Medical Devices (2024-2032) ($MN)
  • Table 17 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 18 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Tablets & Capsules (2024-2032) ($MN)
  • Table 19 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Gummies & Chewables (2024-2032) ($MN)
  • Table 20 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Powders & Drink Mixes (2024-2032) ($MN)
  • Table 21 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Liquids & Syrups (2024-2032) ($MN)
  • Table 22 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Patches & Innovative Formats (2024-2032) ($MN)
  • Table 23 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 24 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 25 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Herbal Extracts & Adaptogens (2024-2032) ($MN)
  • Table 26 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 27 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Omega-3 Fatty Acids (2024-2032) ($MN)
  • Table 28 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Specialty Compounds (2024-2032) ($MN)
  • Table 29 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 30 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 31 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 32 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 33 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Specialty Health Stores (2024-2032) ($MN)
  • Table 34 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Subscription Services (2024-2032) ($MN)
  • Table 35 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Application (2024-2032) ($MN)
  • Table 36 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By PMS Symptom Support (2024-2032) ($MN)
  • Table 37 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Hormonal Balance Regulation (2024-2032) ($MN)
  • Table 38 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Fertility & Cycle Tracking Support (2024-2032) ($MN)
  • Table 39 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menopause & Perimenopause Support (2024-2032) ($MN)
  • Table 40 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Mood & Energy Enhancement (2024-2032) ($MN)
  • Table 41 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Pain & Bloating Relief (2024-2032) ($MN)
  • Table 42 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By End User (2024-2032) ($MN)
  • Table 43 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Adolescents & Teens (2024-2032) ($MN)
  • Table 44 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Women of Reproductive Age (2024-2032) ($MN)
  • Table 45 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Perimenopausal Women (2024-2032) ($MN)
  • Table 46 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Menopausal & Postmenopausal Women (2024-2032) ($MN)
  • Table 47 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Healthcare Providers & Clinics (2024-2032) ($MN)
  • Table 48 Global Women's Hormonal Balance & Menstrual Wellness Products Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.